AMG 157

( DrugBank: AMG 157 / KEGG DRUG: Tezepelumab )

1 disease

ID	Disease name (Link within this page)	Number of trials
98	Eosinophilic gastrointestinal disease	1

98. Eosinophilic gastrointestinal disease

Clinical trials : 172 / Drugs : 149 - (DrugBank : 39) / Drug target genes : 38 - Drug target pathways : 135

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2022-001294-31-DK (EUCTR)	22/11/2022	04/10/2022	Efficacy and Safety of Tezepelumab in Patients with Eosinophilic Esophagitis	A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of ...	Eosinophilic esophagitis (EoE) is a rare, chronic inflammatory disorder triggered by an immune respo ...	Product Name: Tezepelumab via APFS Product Code: MEDI9929 anti-TSLP mAb (AMG157) INN or Proposed INN: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	360	Phase 3	United States;Czechia;Slovakia;Greece;Finland;Spain;Austria;Israel;Italy;Canada;Belgium;Brazil;Denma ...

First Previous1Next Last